Regulation of perforin-independent NK cell-mediated cytotoxicity

European Journal of Immunology

Volumn 33, Issue 10, 2003, Pages 2727-2735

  Wallin, Robert P A ^a,b   Screpanti, Valentina ^b   Michaëlsson, Jakob ^a   Grandien, Alf ^b   Ljunggren, Hans Gustaf ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Apoptosis; Cytotoxicity; FasL; MHC class I; NK cells

Indexed keywords

FAS LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PERFORIN; FASL PROTEIN, MOUSE; HLA ANTIGEN CLASS 1; INTERLEUKIN 2; MEMBRANE PROTEIN; PORE FORMING CYTOTOXIC PROTEIN;

ANIMAL CELL; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; CELL DEATH; CELL SURFACE; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN CROSS LINKING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; BONE MARROW TRANSPLANTATION; CANCER TRANSPLANTATION; CYTOTOXICITY; EXPERIMENTAL NEOPLASM; GRAFT REJECTION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; NATURAL KILLER CELL; PHYSIOLOGY;

ANIMALS; BONE MARROW TRANSPLANTATION; CYTOTOXICITY, IMMUNOLOGIC; FAS LIGAND PROTEIN; GRAFT REJECTION; HISTOCOMPATIBILITY ANTIGENS CLASS I; INTERLEUKIN-2; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; PORE FORMING CYTOTOXIC PROTEINS;

EID: 0242303561     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200324070     Document Type: Article

References (41)

1. Cerwenka, A. and Lanier, L. L., Natural killer cells, viruses and cancer. Nat. Rev. Immunol. 2001. 1: 41-49.
2. Murphy, W. J., Koh, C. Y., Raziuddin, A., Bennett, M. and Longo, D. L., Immunobiology of natural killer cells and bone marrow transplantation: merging of basic and preclinical studies. Immunol. Rev. 2001. 181: 279-289.
3. Biron, C. A., Nguyen, K. B. and Pien, G. C., Innate immune responses to LCMV infections: natural killer cells and cytokines. Curr. Top. Microbiol. Immunol. 2002. 263: 7-27.
4. Guidotti, L. G. and Chisari, F. V., Noncytolytic control of viral infections by the innate and adaptive immune response. Annu. Rev. Immunol. 2001. 19: 65-91.
5. Lanier, L. L., On guard-activating NK cell receptors. Nat. Immunol. 2001. 2: 23-27.
6. Kärre, K., Ljunggren, H. G., Piontek, G. and Kiessling, R., Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 1986. 319: 675-678.
7. Ljunggren, H. G. and Kärre, K., In search of the 'missing self': MHC molecules and NK cell recognition. Immunol. Today 1990. 11: 237-244.
8. Natarajan, K., Dimasi, N., Wang, J., Mariuzza, R. A. and Margulies, D. H., Structure and function of natural killer cell receptors: multiple molecular solutions to self, nonself discrimination. Annu. Rev. Immunol. 2002. 20: 853-885.
9. Burshtyn, D. N., Scharenberg, A. M., Wagtmann, N., Rajagopalan, S., Berrada, K., Yi, T., Kinet, J. P. and Long, E. O., Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. Immunity 1996. 4: 77-85.
10. Nakamura, M. C., Niemi, E. C., Fisher, M. J., Shultz, L. D., Seaman, W. E. and Ryan, J. C., Mouse Ly-49A interrupts early signaling events in natural killer cell cytotoxicity and functionally associates with the SHP-1 tyrosine phosphatase. J. Exp. Med. 1997. 185: 673-684.
11. Kaufman, D. S., Schoon, R. A. and Leibson, P. J., MHC class I expression on tumor targets inhibits natural killer cell-mediated cytotoxicity without interfering with target recognition. J. Immunol. 1993. 150: 1429-1436.
12. Henkart, P. A., Mechanism of lymphocyte-mediated cytotoxicity. Annu. Rev. Immunol. 1985. 3: 31-58.
13. Trapani, J. A. and Smyth, M. J., Functional significance of the perforin/granzyme cell death pathway. Nat. Rev. Immunol. 2002. 2: 735-747.
14. Kägi, D., Ledermann, B., Burki, K., Zinkernagel, R. M. and Hengartner, H., Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu. Rev. Immunol. 1996. 14: 207-232.
15. van den Broek, M. F., Kagi, D., Zinkernagel, R. M. and Hengartner, H., Perforin dependence of natural killer cell-mediated tumor control in vivo. Eur. J. Immunol. 1995. 25: 3514-3516.
16. Smyth, M. J., Thia, K. Y., Cretney, E., Kelly, J. M., Snook, M. B., Forbes, C. A. and Scalzo, A. A., Perforin is a major contributor to NK cell control of tumor metastasis. J. Immunol. 1999. 162: 6658-6662.
17. Eischen, C. M. and Leibson, P. J., Role for NK-cell-associated Fas ligand in cell-mediated cytotoxicity and apoptosis. Res. Immunol. 1997. 148: 164-169.
18. Arase, H., Arase, N. and Saito, T., Fas-mediated cytotoxicity by freshly isolated natural killer cells. J. Exp. Med. 1995. 181: 1235-1238.
19. Kayagaki, N., Yamaguchi, N., Nakayama, M., Takeda, K., Akiba, H., Tsutsui, H., Okamura, H., Nakanishi, K., Okumura, K. and Yagita, H., Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells. J. Immunol. 1999. 163: 1906-1913.
20. Screpanti, V., Wallin, R. P., Ljunggren, H. G. and Grandien, A., A central role for death receptor-mediated apoptosis in the rejection of tumors by NK cells. J. Immunol. 2001. 167: 2068-2073.
21. Ljunggren, H. G. and Kärre, K., Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism. J. Exp. Med. 1985. 162: 1745-1759.
22. Kiessling, R., Hochman, P. S., Haller, O., Shearer, G. M., Wigzell, H. and Cudkowicz, G., Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts. Eur. J. Immunol. 1977. 7: 655-663.
23. Taylor, M. A., Chaudhary, P. M., Klem, J., Kumar, V., Schatzle, J. D. and Bennett, M., Inhibition of the death receptor pathway by cFLIP confers partial engraftment of MHC class I-deficient stem cells and reduces tumor clearance in perforin-deficient mice. J. Immunol. 2001. 167: 4230-4237.
24. Bossi, G. and Griffiths, G. M., Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells. Nat. Med. 1999. 5: 90-96.
25. + cytotoxic T lymphocytes and natural killer cells: participation of Fas ligand in granule exocytosis model of cytotoxicity. Biochem. Biophys. Res. Commun. 2002. 296: 328.
26. Kambayashi, T., Michaelsson, J., Fahlen, L., Chambers, B. J., Sentman, C. L., Kärre, K. and Ljunggren, H. G., Purified MHC class I molecules inhibit activated NK cells in a cell-free system in vitro. Eur. J. Immunol. 2001. 31: 869-875.
27. Michaëlsson, J., Achour, A., Salcedo, M., Kåse-Sjöström, A., Sundbäck, J., Harris, R. A. and Kärre, K., Visualization of inhibitory Ly49 receptor specificity with soluble major histocompatibility complex class I tetramers. Eur. J. Immunol. 2000. 30: 300-307.
28. Eischen, C. M., Schilling, J. D., Lynch, D. H., Krammer, P. H. and Leibson, P. J., Fc receptor-induced expression of Fas ligand on activated NK cells facilitates cell-mediated cytotoxicity and subsequent autocrine NK cell apoptosis. J. Immunol. 1996. 156: 2693-2699.
29. Medvedev, A. E., Johnsen, A. C., Haux, J., Steinkjer, B., Egeberg, K., Lynch, D. H., Sundan, A. and Espevik, T., Regulation of Fas and Fas-ligand expression in NK cells by cytokines and the involvement of Fas-ligand in NK/LAK cell-mediated cytotoxicity. Cytokine 1997. 9: 394-404.
30. Abrams, S. I. and Brahmi, Z., The functional loss of human natural killer cell activity induced by K562 is reversible via an interleukin-2-dependent mechanism. Cell. Immunol. 1986. 101: 558-570.
31. Schneider, P., Holler, N., Bodmer, J. L., Hahne, M., Frei, K., Fontana, A. and Tschopp, J., Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J. Exp. Med. 1998. 187: 1205-1213.
32. Kitson, R. P., Appasamy, P. M., Nannmark, U., Albertsson, P., Gabauer, M. K. and Goldfarb, R. H., Matrix metalloproteinases produced by rat IL-2-activated NK cells. J. Immunol. 1998. 160: 4248-4253.
33. Kim, M. H., Kitson, R. P., Albertsson, P., Nannmark, U., Basse, P. H., Kuppen, P. J., Hokland, M. E. and Goldfarb, R. H., Secreted and membrane-associated matrix metalloproteinases of IL-2-activated NK cells and their inhibitors. J. Immunol. 2000. 164: 5883-5889.
34. Albertsson, P., Kim, M. H., Jonges, L. E., Kitson, R. P., Kuppen, P. J., Johansson, B. R., Nannmark, U. and Goldfarb, R. H., Matrix metalloproteinases of human NK cells. In Vivo 2000. 14: 269-276.
35. Kägi D., Ledermann, B., Burki, K., Seiler, P., Odermatt, B., Olsen, K. J., Podack, E. R., Zinkernagel, R. M. and Hengartner, H., Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 1994. 369: 31-37.
36. van Hall, T., van Bergen, J., van Veelen, P. A., Kraakman, M., Heukamp, L. C., Koning, F., Melief, C. J., Ossendorp, F. and Offringa, R., Identification of a novel tumor-specific CTL epitope presented by RMA, EL-4, and MBL-2 lymphomas reveals their common origin. J. Immunol. 2000. 165: 869-877.
37. Yang, Y., Fruh, K., Chambers, J., Waters, J. B., Wu, L., Spies, T. and Peterson, P. A., Major histocompatibility complex (MHC)-encoded HAM2 is necessary for antigenic peptide loading onto class I MHC molecules. J. Biol. Chem. 1992. 267: 11669-11672.
38. Glas, R., Sturmhofel, K., Hämmerling, G. J., Kärre, K. and Ljunggren, H. G., Restoration of a tumorigenic phenotype by beta 2-microglobulin transfection to EL-4 mutant cells. J. Exp. Med. 1992. 175: 843-846.
39. + T cell development in TAP1/beta 2-microglobulin double-mutant mice. Int. Immunol. 1995. 7: 975-984.
40. Carlson, G. A. and Wegmann, T. G., Rapid in vivo destruction of semi-syngeneic and allogeneic cells by nonimmunized mice as a consequence of nonidentity at H-2. J. Immunol. 1977. 118: 2130-2137.
41. Achour, A., Harris, R. A., Persson, K., Sundbäck, J., Sentman, C. L., Schneider, G., Lindqvist, Y. and Kärre, K., Murine class I major histocompatibility complex H-2Dd: expression, refolding and crystallization. Acta Crystallogr. D. 1999. 55: 260-262.